VK4-116
VK4-116 (Compound 19) is a selective Dopamine D3 receptor (D3R) antagonist with a Ki of 6.84 nM.VK4-116 significantly inhibits Oxycodone-induced hyperlocomotion and locomotor sensitization in mouse models. VK4-116 with pretreatment also inhibits the acquisition of Oxycodone-induced conditioned place preference (CPP) in rat models[1].
Product Specifications
CAS Number
[1982347-43-2]
UNSPSC
12352005
Target
Dopamine Receptor
Related Pathways
GPCR/G Protein; Neuronal Signaling
Field of Research
Neurological Disease
Smiles
O=C(C1=CC2=C(N1)C=CC=C2)NCCC(CN3CCN(CC3)C4=CC(CC)=CC(Cl)=C4OC)O
Molecular Formula
C26H33ClN4O3
Molecular Weight
485.02
References & Citations
[1]Kumar V, et al. Highly Selective Dopamine D3 Receptor (D3R) Antagonists and Partial Agonists Based on Eticlopride and the D3R Crystal Structure: New Leads for Opioid Dependence Treatment. J Med Chem. 2016 Aug 25;59 (16) :7634-50.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
D3 Receptor
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1089482-01 0.02 mg (E-Coli)
Recombinant Streptococcus pneumoniae Probable tautomerase SP_1017 (SP_1017)
Ask
View Details 
MBS1089482-02 0.1 mg (E-Coli)
Recombinant Streptococcus pneumoniae Probable tautomerase SP_1017 (SP_1017)
Ask
View Details MBS1089482-03 0.02 mg (Yeast)
Recombinant Streptococcus pneumoniae Probable tautomerase SP_1017 (SP_1017)
Ask
View Details 
MBS1089482-04 0.1 mg (Yeast)
Recombinant Streptococcus pneumoniae Probable tautomerase SP_1017 (SP_1017)
Ask
View Details MBS1089482-05 0.02 mg (Baculovirus)
Recombinant Streptococcus pneumoniae Probable tautomerase SP_1017 (SP_1017)
Ask
View Details